OPKO Health Inc. (OPK): Price and Financial Metrics
OPK Price/Volume Stats
| Current price | $1.02 | 52-week high | $2.24 |
| Prev. close | $1.00 | 52-week low | $0.85 |
| Day low | $0.99 | Volume | 4,085,500 |
| Day high | $1.04 | Avg. volume | 21,397,941 |
| 50-day MA | $1.28 | Dividend yield | N/A |
| 200-day MA | $1.54 | Market Cap | 788.52M |
OPK Stock Price Chart Interactive Chart >
OPK POWR Grades
- Growth is the dimension where OPK ranks best; there it ranks ahead of 64.86% of US stocks.
- OPK's strongest trending metric is Quality; it's been moving up over the last 26 weeks.
- OPK's current lowest rank is in the Momentum metric (where it is better than 26.24% of US stocks).
OPK Stock Summary
- OPK's went public 28.19 years ago, making it older than 72.54% of listed US stocks we're tracking.
- Equity multiplier, or assets relative to shareholders' equity, comes in at 1.4 for OPKO HEALTH INC; that's greater than it is for only 21.55% of US stocks.
- As for revenue growth, note that OPK's revenue has grown -28.95% over the past 12 months; that beats the revenue growth of merely 9.43% of US companies in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to OPKO HEALTH INC are SHPW, CARS, HCTI, OSPN, and CMTL.
- Visit OPK's SEC page to see the company's official filings. To visit the company's web site, go to www.opko.com.
OPK Valuation Summary
- OPK's EV/EBIT ratio is -6.6; this is 145.21% lower than that of the median Healthcare stock.
- OPK's price/earnings ratio has moved down 4.1 over the prior 243 months.
Below are key valuation metrics over time for OPK.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| OPK | 2023-12-29 | 1.3 | 0.8 | -5.6 | -6.6 |
| OPK | 2023-12-28 | 1.4 | 0.8 | -5.9 | -6.8 |
| OPK | 2023-12-27 | 1.4 | 0.8 | -5.9 | -6.8 |
| OPK | 2023-12-26 | 1.4 | 0.9 | -6.0 | -7.0 |
| OPK | 2023-12-22 | 1.4 | 0.9 | -6.0 | -6.9 |
| OPK | 2023-12-21 | 1.4 | 0.9 | -6.0 | -6.9 |
OPK Growth Metrics
- The 2 year net income to common stockholders growth rate now stands at 60.23%.
- Its 4 year net income to common stockholders growth rate is now at -565.08%.
- The 2 year price growth rate now stands at 4.27%.
The table below shows OPK's growth in key financial areas (numbers in millions of US dollars).
| Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
|---|---|---|---|
| 2022-09-30 | 1,220.187 | -69.212 | -316.948 |
| 2022-06-30 | 1,426.256 | -3.58 | -202.118 |
| 2022-03-31 | 1,558.771 | -7.556 | -116.654 |
| 2021-12-31 | 1,774.718 | 38.337 | -30.143 |
| 2021-09-30 | 1,868.06 | 78.238 | 75.929 |
| 2021-06-30 | 1,910.311 | 107.853 | 70.907 |
OPK's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- OPK has a Quality Grade of C, ranking ahead of 62.7% of graded US stocks.
- OPK's asset turnover comes in at 0.76 -- ranking 36th of 682 Pharmaceutical Products stocks.
- LFVN, GBT, and SYRS are the stocks whose asset turnover ratios are most correlated with OPK.
The table below shows OPK's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-09-30 | 0.760 | 0.347 | 0.102 |
| 2021-06-30 | 0.781 | 0.347 | 0.094 |
| 2021-03-31 | 0.730 | 0.368 | 0.140 |
| 2020-12-31 | 0.611 | 0.377 | 0.063 |
| 2020-09-30 | 0.505 | 0.384 | -0.079 |
| 2020-06-30 | 0.418 | 0.392 | -0.157 |
OPK Price Target
For more insight on analysts targets of OPK, see our OPK price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $6.60 | Average Broker Recommendation | 1.2 (Strong Buy) |
OPKO Health Inc. (OPK) Company Bio
OPKO Health is a multinational biopharmaceutical and diagnostics company that seeks to establish industry leading positions in large, rapidly growing markets by leveraging its discovery, development and commercialization expertise and novel and proprietary technologies. The company was founded in 2005 and is based in Miami, Florida.
Latest OPK News From Around the Web
Below are the latest news stories about OPKO HEALTH INC that investors may wish to consider to help them evaluate OPK as an investment opportunity.
OPKO Health commences private offering of convertible senior notesMore on OPKO Health... |
Here's Why You Should Retain OPKO Health (OPK) Stock for NowOPKO Health's (OPK) potential in Rayaldee raises optimism about the stock. |
Why Is OPKO Health (OPK) Up 18.7% Since Last Earnings Report?OPKO Health (OPK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. |
BioReference Health and Prognos Health Collaborate to Advance Precision Medicine and TestingBioReference® Health, LLC (BRH), a leading specialty laboratory in the United States, announced a strategic collaboration with Prognos Health, a pioneer in providing accessible, quality real world data ("RWD") for the pharmaceutical and life science industries. This collaborative arrangement will offer healthcare providers and researchers unique solutions to inform clinical studies and improve patient outcomes. Combining genetic data and critical biomarkers, means targeted precision therapies ba |
Phillip Frost Spends US$1.3m On OPKO Health StockThose following along with OPKO Health, Inc. ( NASDAQ:OPK ) will no doubt be intrigued by the recent purchase of shares... |
OPK Price Returns
| 1-mo | -1.92% |
| 3-mo | -19.05% |
| 6-mo | -43.65% |
| 1-year | -20.31% |
| 3-year | -81.75% |
| 5-year | -62.08% |
| YTD | -32.45% |
| 2023 | 20.80% |
| 2022 | -74.01% |
| 2021 | 21.77% |
| 2020 | 168.71% |
| 2019 | -51.16% |
Continue Researching OPK
Want to see what other sources are saying about Opko Health Inc's financials and stock price? Try the links below:Opko Health Inc (OPK) Stock Price | Nasdaq
Opko Health Inc (OPK) Stock Quote, History and News - Yahoo Finance
Opko Health Inc (OPK) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...